| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $289,013,128 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR084430 | The role of mechanosensing and mechanotransduction in joint homeostasis and osteoarthritis susceptibility | 000 | 1 | NIH | 7/10/2025 | $691,089 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R13EB038076 | Medical Imaging with Deep Learning (MIDL) Conference 2025 | 000 | 1 | NIH | 7/4/2025 | $10,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS142383 | Pathophysiologic Nerve Regeneration | 001 | 1 | NIH | 9/23/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS142383 | Pathophysiologic Nerve Regeneration | 000 | 1 | NIH | 7/10/2025 | $594,115 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21DC022648 | Neural basis of precedence-type sound localization processes | 000 | 1 | NIH | 3/20/2025 | $189,530 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL181498 | Integrating multi-omics data to understand the heterogeneity of preeclampsia and long-termpostpartum hypertension | 000 | 1 | NIH | 9/5/2025 | $524,179 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21NR021748 | A real-time surveillance system for detecting local spikes of food insecurity to inform timely interventions | 000 | 1 | NIH | 9/12/2025 | $423,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UH3AT012859 | Holistic Pain Care in Military Health System | 000 | 2 | NIH | 9/5/2025 | $1,159,049 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UH3AT012859 | Holistic Pain Care in Military Health System | 000 | 2 | NIH | 9/5/2025 | $100,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31DK141265 | Clec12A regulation of the intestinal immune response and microbiota composition | 001 | 1 | NIH | 9/10/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31DK141265 | Clec12A regulation of the intestinal immune response and microbiota composition | 000 | 1 | NIH | 9/10/2025 | $42,418 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08CA252883 | Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia | 000 | 4 | NIH | 3/13/2025 | $289,908 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR082973 | Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility | 001 | 2 | NIH | 5/7/2025 | $40,841 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR082973 | Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility | 000 | 2 | NIH | 3/7/2025 | $525,081 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33HL171790 | Trans Nasal Transesophageal Echocardiography | 000 | 2 | NIH | 8/21/2025 | $385,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00HD111686 | Understanding genomic stability between generations by assessing mutational burdens in single sperms | 000 | 4 | NIH | 8/14/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31HL182262 | Understanding Uncertainty and Improving Parameterization of In-Silico Cardiac Electrophysiology Models | 000 | 1 | NIH | 8/18/2025 | $38,870 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31HL182262 | Understanding Uncertainty and Improving Parameterization of In-Silico Cardiac Electrophysiology Models | 001 | 1 | NIH | 8/18/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL177046 | Incorporating Donor Lung CT Images into Machine Learning Models to Predict Severe Primary Graft Dysfunction after Lung Transplantation | 000 | 1 | NIH | 8/15/2025 | $782,289 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R50EB038027 | Advancing Medical Imaging Software with Machine Learning for NIH-Supported Research | 000 | 1 | NIH | 8/15/2025 | $145,551 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32AG092002 | Advanced Imaging and Assistive Devices to Uncover and Address Novel Mechanisms of Age-Related Mobility Deficits | 000 | 1 | NIH | 8/15/2025 | $76,638 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32AG092002 | Advanced Imaging and Assistive Devices to Uncover and Address Novel Mechanisms of Age-Related Mobility Deficits | 002 | 1 | NIH | 9/17/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31AI195009 | Investigating the Role HIV Viral gRNA and Gag-Pol Incorporation in HIV-1 Maturation | 000 | 1 | NIH | 8/18/2025 | $38,772 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32AG092002 | Advanced Imaging and Assistive Devices to Uncover and Address Novel Mechanisms of Age-Related Mobility Deficits | 001 | 1 | NIH | 9/17/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 001 | 8 | NIH | 6/3/2025 | $38,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32GM154406 | Dynamic Modeling of Dicer Function | 001 | 1 | NIH | 8/20/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 000 | 8 | NIH | 3/7/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32GM154406 | Dynamic Modeling of Dicer Function | 000 | 1 | NIH | 8/20/2025 | $75,520 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01NS120901 | A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | 002 | 3 | NIH | 9/16/2025 | -$50,489 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01NS120901 | A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | 003 | 4 | NIH | 9/17/2025 | $50,489 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K99DA061935 | Building evidence for effective extended-release buprenorphine treatment for opioid use disorder | 000 | 1 | NIH | 6/26/2025 | $201,960 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK141070 | Mechanisms underlying the functional regulation of the gut microbiota by intestinal epithelial cells to maintain intestinal homeostasis | 000 | 1 | NIH | 8/21/2025 | $835,564 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01NS120901 | A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | 001 | 4 | NIH | 8/18/2025 | $3,478,888 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01NS120901 | A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | 000 | 3 | NIH | 7/15/2025 | $50,489 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K22NS123547 | The role of Infiltrating Macrophages in Seizure Generation Following CNS Infection | 003 | 5 | NIH | 7/30/2025 | $273,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD117622 | Rural and Urban Differences in Pubertal Development and Menstrual Characteristics in a Costa Rican Cohort | 001 | 1 | NIH | 7/31/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD117622 | Rural and Urban Differences in Pubertal Development and Menstrual Characteristics in a Costa Rican Cohort | 000 | 1 | NIH | 7/31/2025 | $40,290 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH132822 | Prefrontal Circuit Control of Isolation-Induced Aggression | 000 | 3 | NIH | 2/13/2025 | $486,185 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23HL157751 | A theory-based practice guide for creating patient education | 000 | 4 | NIH | 2/20/2025 | $149,623 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U24NS107156 | The Utah Regional Network for Excellence in Neuroscience Clinical Trials (UR-NEXT) | 002 | 8 | NIH | 6/12/2025 | $423,100 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL165119 | The Pathophysiology of Type 1 Versus Type 2 Mutant Calreticulin-Drivenmyeloproliferative Neoplasms | 002 | 4 | NIH | 8/14/2025 | $463,672 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS140319 | Overcoming Therapy Resistance in Hedgehog Pathway-Driven Medulloblastoma | 000 | 1 | NIH | 7/31/2025 | $611,591 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG083580 | Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancer | 001 | 2 | NIH | 6/10/2025 | $61,985 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG083580 | Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancer | 000 | 2 | NIH | 3/20/2025 | $697,349 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA294770 | Elucidating the functional role and therapeutic potential of GPCR kinase 2 in primary and therapy-resistant basal cell carcinoma | 000 | 1 | NIH | 8/5/2025 | $669,949 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM160200 | Xenobiotic induction mechanisms affecting pharmacokinetics and pharmacodynamics among medically complex children, adolescents, and young adults. | 000 | 1 | NIH | 8/11/2025 | $2,117,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R34AT013448 | Waning Moon: A Whole Person Health Intervention Designed by and for Urban Menopausal American Indian/Alaska Native Women | 000 | 1 | NIH | 8/26/2025 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R34AT013448 | Waning Moon: A Whole Person Health Intervention Designed by and for Urban Menopausal American Indian/Alaska Native Women | 000 | 1 | NIH | 8/26/2025 | $100,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL180520 | Novel Roles for IRE1 in Regulating Cardiac Fibrosis | 000 | 1 | NIH | 8/28/2025 | $745,663 |
|
